BUSINESS REGISTRATION NUMBER
BRN 14115243

PACIFIC PHARMACO LIMITED

(海運藥業有限公司)

Registry Verified: 2026-11-11
Jurisdiction: Hong Kong, China

PACIFIC PHARMACO LIMITED ((海運藥業有限公司)) is a Hong Kong corporation duly incorporated under the Companies Ordinance (Cap. 622), legally classified as a Private company limited by shares. Its official Company Registration Number (CR No. / CRN) is 0288404, and Business Registration Number (BRN) is 14115243. Incorporated on 1990-10-02, the entity has maintained continuous statutory operations for 36 years and 1 month, currently holding an active legal status of Live. The registered office is situated at G/F, WAH MAY BUILDING, 36D-E SHANTUNG STREET, MONG KOK, KOWLOON, HONG KONG. Regarding statutory filings, pursuant to Section 662 of the Companies Ordinance (Cap. 622), its annual return filing window falls between Oct 02 – Nov 13 (within 42 days after its incorporation anniversary), with the latest Annual Return (Form NAR1) officially filed on 2025-10-23; a total of 10 statutory filings (spanning 2018–2025, latest filed on 2025-10-23) are indexed in the registry, comprising 8 Annual Return(s) (NAR1), 1 officer/secretary change notice(s) (ND2A).

I. Statutory Registry Records & Hong Kong Shelf & Vintage Firms Background Verification

Official Chinese Name (海運藥業有限公司) Official English Name PACIFIC PHARMACO LIMITED
Name Evolution
(1 Former Name)
1990-10-02 Founding Incorp. Name
海運葯房有限公司PACIFIC PHARMACY LIMITED
Current Legal Name
(海運藥業有限公司)PACIFIC PHARMACO LIMITED
Company Reg No. (CRN) 0288404 Business Reg No. (BRN)
14115243
Incorporation Date 1990-10-02 Company Category Private company limited by shares
Current Legal Status Live Statutory Filing Cycle
2026-10-02
Registered Office Address
G/F, WAH MAY BUILDING, 36D-E SHANTUNG STREET, MONG KOK, KOWLOON, HONG KONGWah May Building · View Co-Located Entities →
Significant Controllers (SCR) Statutorily maintained. To penetrate ultimate beneficial owners (UBO) and holding structures, please apply for a Due Diligence Report.

II. Companies Registry Document Retrieval(Annual Return NAR1 & ND2A Filings)

#Filing DateDocument No.Document NamePagesTariffAction
12025-10-2323002533447
NAR1
Annual Return (2025) (English)Latest Shareholders & Directors
13HK$ 28
22024-10-2223102322525
NAR1
Annual Return (2024) (English)
13HK$ 28
32023-12-27SH000083349
BRN_REF
Reference Document for Business Registration Number as UBI
1HK$ 30
42023-10-2623102163462
NAR1
Annual Return (2023) (English)
11HK$ 28
52023-04-1322001348325
ND2B
Notice of Change of Company Secretary and Director (Particulars) (English)
3HK$ 20
62022-10-2022702557621
NAR1
Annual Return (2022) (English)
11HK$ 28
72021-10-2023601585228
NAR1
Annual Return (2021) (English)
11HK$ 28
82020-10-3023101788494
NAR1
Annual Return (2020) (English)
11HK$ 28
92019-10-2922802034415
NAR1
Annual Return (2019) (English)
11HK$ 28
102018-10-2623401587316
NAR1
Annual Return (2018) (English)
11HK$ 28

III. Commercial Due Diligence & Regulatory Risk Screening

Cross-screened across 32 HK statutory regulators, court dockets & sanctions registers: 0 licences, 0 public litigation/HCCW records, 0 sanctions hits.

IV. Corporate Statutory Dossier & Legal Status FAQ

Yes. PACIFIC PHARMACO LIMITED is a legitimate Hong Kong corporation (Private company limited by shares) duly incorporated under the Companies Ordinance (Cap. 622) on 1990-10-02 (operating for 36 years). According to official registers of the Hong Kong Companies Registry (CR), the entity holds an active statutory standing of [Live / In Operation], possessing independent legal personality and full corporate capacity (Statutory verification: November 2026).

The statutory primary identifiers for PACIFIC PHARMACO LIMITED are: 1. Business Registration Number (BRN / Unique Business Identifier UBI): [14115243] (effective from 27 December 2023, this 8-digit number issued under Cap. 310 serves as the unified cross-departmental corporate identifier); 2. Company Registration Number (CRN): [0288404] (incorporation archive number issued under Cap. 622). Together, these dual keys uniquely lock the entity in international banking KYC and cross-border contracts.

Under the Companies Ordinance (Cap. 622) of Hong Kong, incorporated companies do not maintain a single 'legal representative' position; the Board of Directors (Section 643) exercises statutory management authority. Complete current and historical directorships (Form ND2A), registered member shareholdings (Form NAR1 / Section 627), and Ultimate Beneficial Ownership (UBO / SCR under Part 12 Division 2A) are verified through official statutory filing retrieval.

Yes. According to the official statutory records of the Hong Kong Companies Registry, PACIFIC PHARMACO LIMITED has officially recorded 1 legal name change(s): [PACIFIC PHARMACY LIMITED (海運葯房有限公司) (effective 1990-10-02)]. Pursuant to Sections 107 and 109 of the Companies Ordinance (Cap. 622), each name change was passed by special resolution (Form NNC2) and took statutory effect upon issuance of a Certificate of Change of Name by the Registrar of Companies; under Section 109(4), changing the company name does not affect any rights, obligations, or legal proceedings of the company.

Yes. Statutory indexing confirms that PACIFIC PHARMACO LIMITED has accumulated 10 official filing dossier(s) archived in the Hong Kong Companies Registry (latest statutory filing indexed on 2025-10-23: Form NAR1 - Annual Return (2025) (English)). Pursuant to Section 662 of the Companies Ordinance (Cap. 622), private companies must deliver an Annual Return (Form NAR1) within 42 days after each incorporation anniversary. Available barcoded dossiers include: latest Annual Return (Form NAR1 - detailing current share capital, registered office, directors, and member shareholdings), Incorporation Form (Form NNC1), Articles of Association, and Change of Company Secretary and Director notices (Form ND2A), each bearing authentic ICRIS electronic barcode verification.

The statutory registered office of PACIFIC PHARMACO LIMITED on official record is situated at: [G/F, WAH MAY BUILDING, 36D-E SHANTUNG STREET, MONG KOK, KOWLOON, HONG KONG]. Pursuant to Section 658 of the Companies Ordinance (Cap. 622), every Hong Kong company must maintain a registered office in Hong Kong to which all communications and legal notices may be addressed, and file Form NR1 within 15 days of any address change.

Retrieve Filings